Results 71 to 80 of about 872,770 (359)

Lynch Job Approval Hits Record High 4/11/2007 [PDF]

open access: yes, 2007
New Hampshire Governor John Lynch continues to enjoy extremely high job approval.
Survey Center, UNH
core   +1 more source

Next‐generation proteomics improves lung cancer risk prediction

open access: yesMolecular Oncology, EarlyView.
This is one of very few studies that used prediagnostic blood samples from participants of two large population‐based cohorts. We identified, evaluated, and validated an innovative protein marker model that outperformed an established risk prediction model and criteria employed by low‐dose computed tomography in lung cancer screening trials.
Megha Bhardwaj   +4 more
wiley   +1 more source

The technical roadmap of the development of variable pitch propeller governors for turboprop

open access: yesHangkong gongcheng jinzhan
The variable pitch governor controls the propeller to maintain a constant speed,so that the propeller can be energy-saving and efficient in a wider range of flight envelope.
CHEN Tingting, GUO Yong, PAN Zhongjian
doaj   +1 more source

Sununu\u27s Job Approval Falls From All-Time High; Bipartisan Optimism About NH Overall 4/23/2019 [PDF]

open access: yes, 2019
Governor Chris Sununu\u27s job approval has declined from an all-time high in February, but his approval mirrors that of his predecessor Maggie Hassan at the same point in her governorship. Only four in ten Democrats approve of Sununu\u27s performance as
UNH Survey Center
core   +1 more source

Effective therapeutic targeting of CTNNB1‐mutant hepatoblastoma with WNTinib

open access: yesMolecular Oncology, EarlyView.
WNTinib, a Wnt/CTNNB1 inhibitor, was tested in hepatoblastoma (HB) experimental models. It delayed tumor growth and improved survival in CTNNB1‐mutant in vivo models. In organoids, WNTinib outperformed cisplatin and showed enhanced efficacy in combination therapy, supporting its potential as a targeted treatment for CTNNB1‐mutated HB.
Ugne Balaseviciute   +17 more
wiley   +1 more source

Interregional Cooperation in SCO format: Outcomes and Potential for the Novosibirsk Region

open access: yesМеждународная аналитика, 2015
The paper deals with regional cooperation of Novosibirsk region and city of Novosibirsk with SCO countries. The rich scientific, technical and educational potential as well as its geographical position can be considered as optimal place for all sorts of ...
S. Sannikov
doaj   +1 more source

LINC01116, a hypoxia‐lncRNA marker of pathological lymphangiogenesis and poor prognosis in lung adenocarcinoma

open access: yesMolecular Oncology, EarlyView.
The LINC01116 long noncoding RNA is induced by hypoxia and associated with poor prognosis and high recurrence rates in two cohorts of lung adenocarcinoma patients. Here, we demonstrate that besides its expression in cancer cells, LINC01116 is markedly expressed in lymphatic endothelial cells of the tumor stroma in which it participates in hypoxia ...
Marine Gautier‐Isola   +12 more
wiley   +1 more source

RETHINKING MACROECONOMY AND CENTRAL BANKING IN THE NEW NORMAL

open access: yesBuletin Ekonomi Moneter dan Perbankan, 2021
Perry Warjiyo
doaj   +1 more source

Hopf Bifurcations in a Watt Governor With a Spring

open access: yes, 2008
This paper pursues the study carried out by the authors in "Stability and Hopf bifurcation in a hexagonal governor system", focusing on the codimension one Hopf bifurcations in the hexagonal Watt governor differential system.
Al-Humadi A   +13 more
core   +1 more source

PARP inhibition and pharmacological ascorbate demonstrate synergy in castration‐resistant prostate cancer

open access: yesMolecular Oncology, EarlyView.
Pharmacologic ascorbate (vitamin C) increases ROS, disrupts cellular metabolism, and induces DNA damage in CRPC cells. These effects sensitize tumors to PARP inhibition, producing synergistic growth suppression with olaparib in vitro and significantly delayed tumor progression in vivo. Pyruvate rescue confirms ROS‐dependent activity.
Nicolas Gordon   +13 more
wiley   +1 more source

Home - About - Disclaimer - Privacy